ABSTRACT Background: Micronutrient deficiencies may be related to poor fetal growth and short gestation. Few studies have investigated the contribution of maternal vitamin A deficiency to these outcomes. Objective: In rural northwestern Bangladesh, we examined the effects of weekly antenatal vitamin A and b-carotene supplementation on birth weight, length, circumferential body measures, and length of gestation. Design: With the use of a cluster-randomized, placebo-controlled trial design, pregnant women were enrolled in the first trimester and began receiving their allocated supplements (vitamin A, b-carotene, or placebo) weekly until 3 mo postpartum. Birth anthropometric measures were made at home. Results: Of 13,709 newborns whose birth weight was measured within 72 h of birth, mean (6SD) weight was 2.44 6 0.42 kg, the prevalence of low birth weight (LBW) was 54.4%, and that of smallfor-gestational age (SGA) was 70.5%. Birth weight, length, and chest, head, and arm circumferences did not differ between supplementation and placebo groups nor did rates of LBW and SGA. Mean gestational age at birth was 38.3 6 2.9 wk, and 25.6% of births occurred before 37 wk. Neither gestational age nor preterm birth rate differed with vitamin A or b-carotene supplementation. Conclusions: In this rural South Asian population with a high burden of LBW and preterm birth but modest levels of maternal vitamin A deficiency, antenatal vitamin A or b-carotene supplementation did not benefit these birth outcomes. Other nutritional and nonnutritional interventions should be examined to reduce risks of these adverse outcomes in rural South Asia. This trial was registered at clinicaltrials. gov as NCT00198822.
INTRODUCTION
Low birth weight (LBW) 4 continues to be a major public health problem worldwide, affecting the immediate and longterm health of infants in both developed and developing countries (1, 2) . Both fetal growth restriction and preterm birth contribute to the large burden of LBW. Most growth-restricted or small-for-gestational age (SGA) infants are born in lowincome countries (2) . The prevalence of LBW in South Asia is estimated to be w30%, which represents half of all LBW infants in the world. Numerous factors, including maternal nutrition, can lead to these poor birth outcomes. Among these factors are vitamin and mineral deficiencies, which constitute a major public health problem among pregnant women in many settings (3) (4) (5) . Of interest is maternal vitamin A deficiency, which, by WHO estimates, is present in 19 million pregnant women globally on the basis of low serum retinol (,0.7 mmol/L) (6).
Older cross-sectional studies reviewed previously (7, 8) suggest a positive association between vitamin A concentration in cord blood and fetal growth, although such relationships may not be causal, are possibly bidirectional, and are likely confounded by a positive correlation between cord plasma retinol and gestational age (r = 0.15-0.36) in term-born infants (8) . Recent observational studies have found maternal and cord blood vitamin A status to be significantly associated with birth weight and length and head circumference (9) (10) (11) . A clinic-based study in India showed maternal serum retinol ,0.7 mmol/L to be associated with preterm delivery (P = 0.02) after adjustment for BMI, parity, age, and socioeconomic status (12) . In rural South India, maternal night blindness increased the risk of LBW (adjusted RR: 1.13; 95% CI: 1.01, 1.26) and very LBW (,1500 g) (adjusted RR: 3.38; 95% CI: 1.18, 6.33) (13) . Two placebocontrolled trials have previously tested the effect of maternal vitamin A supplementation on birth or neonatal size. One showed no effect of supplementation with vitamin A plus b-carotene among pregnant HIV-positive Tanzanian women on outcomes of LBW, preterm birth, and SGA (14) . In Nepal, weekly supplementation with vitamin A [7000 mg retinol equivalents (REs) or 42 mg b-carotene] had no effect on weight and other anthropometric variables, as measured in 954 infants between 7 and 14 d of age, compared with the placebo (8) .
In a rural northwestern population in Bangladesh, we recently reported the results of weekly vitamin A and b-carotene supplementation during pregnancy and the postpartum period (n z 60,000) on outcomes of pregnancy-related and infant mortality (15) . We found no effect of either intervention on these primary outcomes. In this study, we examined the effects of vitamin A and b-carotene supplementation on birth size, including weight, length, and circumferential measures taken within 72 h of birth and on risks of LBW and being born either SGA or preterm.
SUBJECTS AND METHODS

Study area, population, and design
From 2001 to 2007, a large, randomized, placebo-controlled trial called JiVitA-1 was undertaken to test the effect of antenatal through postnatal vitamin A and b-carotene supplementation on pregnancyrelated mortality in a rural northwestern community of Gaibandha and Rangpur districts of Bangladesh (16) . Neither supplement was found to reduce the risk of maternal or infant mortality (15) . The detailed methods of this trial were described previously (15, 16) . Randomization was done by predefined household clusters called sectors (n = 596) by using a random numbers table across a 435-km 2 study area. Briefly, at the outset, married women of reproductive age were enumerated and consented to participate in pregnancy surveillance, which entailed a 5-weekly visit to assess menstrual history and to measure human chorionic gonadotropin in urine to ascertain a pregnancy when a woman reported having missed her menstrual period in the past 30 d.
After a woman was confirmed as being pregnant, she was asked to provide consent again and enrolled to begin receiving her sector-specific allocation supplement. Over a period of w6 y of enrollment, 59,721 pregnant women consented and were enrolled into the trial (15) .
The study received ethical approval from the institutional review board of the Johns Hopkins School of Public Health in Baltimore, Maryland, and the Bangladesh Medical Research Council in Bangladesh. Oral consent was obtained from women before enrollment in the study for participation in the trial and in the third trimester for the birth assessments.
Intervention
The 3 supplements were a placebo, vitamin A, and b-carotene capsule provided once every week from the time of pregnancy enrollment until 3 mo postpartum. The supplements were identical in shape, size, and color, and the investigators, field staff, and data collectors were blinded to the codes, which were further masked by using sector numbers on the bottles used for dispensing supplements (15) . Vitamin A was provided in the form of retinyl palmitate at 23,300 IU or 7000 mg REs in soybean oil, and b-carotene was in the form of all-trans b-carotene (42 mg or 7000 mg REs by using a conversion ratio of 6:1) (17) . These amounts were a weekly dose of an approximate Recommended Dietary Allowance for pregnant or lactating women of 1000 mg REs. Local women, one per sector, were hired to deliver the intervention, which was directly observed being taken for on average $65% of the entire duration of the intervention. The remaining doses were left at home to be taken by the woman, unobserved, and adherence was assessed by pill count and recall. Supplement distribution and compliance and pregnancy outcomes were monitored by the local female staff. Adherence to supplementation in the study was high, ie, w94% across the 3 supplement groups (15) .
Baseline interview
On enrollment, women were visited by trained female interviewers to conduct a baseline interview related to their previous pregnancy history and to obtain a 7-and 30-d history of morbidities experienced, 7-d food-frequency intakes, work patterns, and consumption of cigarettes, alcohol, chewing tobacco, and betel nut. In addition, interviews were conducted to elicit data on household sociodemographic characteristics, asset ownership, and house construction. Midupper arm circumference (MUAC) of pregnant women was measured in triplicate by using an insertion tape to derive a median of 3 measurements.
Assessment of outcomes
Gestational age was assessed by using the reported first date of the last menstrual period (LMP). The recall of this date was aided by the 5-weekly assessment of menstrual histories that were used to administer pregnancy tests. The LMP date was ascertained at the time of the pregnancy enrollment interview, which was conducted soon after detection of pregnancy, thereby shortening the recall period. Almost 85% of the pregnant women were enrolled within 12 wk of gestation. Local events calendars were used to facilitate recall. In addition, we also cross-checked the reported LMP with the date of the positive urine test. Date of birth is also important in the assessment of the gestational length of a pregnancy. Our birth notification system allowed our workers to know precisely when an infant was born and to record the date and time of birth. Ultrasound-based gestational age was considered unfeasible given the large sample size, and low rates of antenatal care and Ballard scores were not determined because .90% of women delivered at home-most without a trained skilled attendant. LMP dates yielding a gestational age of ,28 wk among liveborn infants were considered invalid because, in this setting, in which 90% of deliveries occurred at home and newborn care is limited, the viability of births occurring this early in gestation is deemed to be low (n = 639). Also, gestational ages .44 wk were considered implausible and discarded (n = 1375).
In 2004, after 3 y of enrollment in the study, a second trial of newborn vitamin A supplementation, called JiVitA-2, was nested within the larger pregnancy trial to test the effect of a 50,000-IU single dose on 6-mo infant mortality (18) . As part of this nested study, a new birth notification system was set up to reach newborns, of whom 90% were delivered at home, within 1-2 d of life for vitamin A supplementation. In JiVitA-2 we also initiated birth assessments conducted by our trained team of 56 female anthropometrists, who were equipped with measuring scales and length boards and visited the homes of the newborns to conduct an interview and measure infant weight, length, and head, chest, and arm circumferences. Neither procedure was in place for infants born before February 2004. Birth weight was measured by using a Tanita BD-585 digital scale (Tanita Corporation), which measured weight to the nearest 10 g. Length was measured to the nearest 0.1 cm by using an infant length board modified after the Infant Shorr board (Shorr Productions) but with the use of local materials. Circumferential measurements were made by using a Ross insertion tape (Abbott Laboratories). Each measurement other than weight was made 3 times, and the median of each was used as the final measurement.
Statistical analysis
Data for this analysis included singleton liveborn infants across all pregnancies enrolled in the JiVitA-1 trial for outcomes of preterm and gestational length. For outcomes of birth anthropometry, the analysis included singleton liveborn infants whose birth assessment was conducted as part of the JiVitA-2 trial. Gestational age at birth was calculated by using the date of LMP and the date of birth of the infant. Preterm was defined as gestational age at birth ,37 completed weeks. Preterm birth prevalence was estimated both in the full sample and among the sample in which birth weight was taken. In the latter sample, we also estimated the prevalence of LBW, defined as weight ,2500 g measured within 72 h of birth. SGA was defined as birth weight measured within 72 h less than the 10th percentile for a given gestational age and sex by using the Alexander USfetal growth reference (19) . Ponderal index, used to identify fetal growth restriction by identifying infants with asymmetric growth, was calculated as weight (kg)/length (m) 3 and defined as ,10th percentile by using gestational age-specific percentiles for ponderal index (20) . Baseline maternal and household characteristics were examined by supplement group to ensure comparability between randomized treatment groups. A previously created composite index reflecting housing material and durable asset ownership, determined by using principal components analysis (21) with 20.259 representing the median index score for households in the placebo group of the larger maternal trial, was used to examine differences in the proportion of households with a low index by supplement group. The positive tail of the score distribution, indicating higher socioeconomic status, stretches upward of +3, but most of the population remains between the bounds of 21.5 to +1. Treatment effects were examined by using intention-to-treat analysis. Difference in gestational age at birth and continuous anthropometric outcomes were estimated by using a generalized estimating equation linear regression model with a normal link and an exchangeable correlation structure to adjust for the cluster-randomized design. Generalized estimating equation logistic regression with a log link and an exchangeable correlation structure was used to estimate RRs and 95% CIs for dichotomous outcomes of LBW, preterm, and SGA with the placebo as the referent group. All analyses were done by using SAS version 9.2 statistical software (SAS Inc). 
birth, and 13,709 (75.1%) had birth weight assessed within 72 h of being born. Data on birth weight were missing because of early infant deaths (n = 653), not met/moved (n = 55), missing birth weight data (n = 321), and birth weight measurement taken after 72 h (n = 3,512).
The characteristics of the women did not differ by supplement group across a range of variables, including maternal age, parity, MUAC, 7-d histories of food intake, and tobacco and alcohol use ( Table 1) . Household socioeconomic status assessed by a living standards index was lower than the median value of 20.259 in w42% of the households. A large majority of the population was Muslim (.90%). Gestational age at enrollment was within the first trimester among w77% of the women. The mean (6SD) birth weight in the placebo group was 2447 6 427 g, and the mean differences (95% CI) in the vitamin A and b-carotene groups were 0 (218, 17) g (P = 0.97) and 218 (237, 0) g (P = 0.06), respectively ( Table 2) . Mean (6SD) birth length was 46.4 6 2.5 cm and did not differ by supplementation. The same results were observed on the basis of calculated ponderal index and circumferential measures of head, chest, and midupper arm. The mean (6SD) gestational age at birth was 38.3 6 2.9 wk in the placebo group, and the values in the vitamin A and b-carotene groups were virtually identical to that in the placebo.
The prevalence of LBW was high (53.4%) in the placebo group and did not differ by supplement group ( Table 3) . The same was evident for the 2 underlying contributors to LBW, ie, fetal growth restriction and preterm birth. The prevalence of SGA was 70.2%, and preterm birth occurred at 22.5% in the placebo group; no significant difference was observed by treatment group. When preterm birth was examined in the full sample of women in the trial, for whom the LMP date was available, we found its prevalence to be 25.9%. The rate of very preterm birth (,34 wk) was 8.5% in the placebo group, which did not differ from that in the vitamin A (RR: 0.96; 95% CI: 0.87, 1.06) or b-carotene (RR: 0.98; 95% CI: 0.90, 1.08) supplementation group (data not shown).
DISCUSSION
In a rural Bangladeshi setting, with the use of a home-based assessment of birth anthropometric measures among w14,000 newborns, we found LBW, SGA, and preterm birth prevalence rates of 53.4%, 65.6%, and 22.5%, respectively, which suggests a high burden of fetal growth restriction and preterm birth related to maternal undernutrition, including poor prepregnancy status and other environmental factors. A fifth of the women had an MUAC ,21.5 cm-an indicator of moderate to severe wasting. And yet, as evaluated by a randomized, placebo-controlled trial, weekly vitamin A or b-carotene supplementation did little to ameliorate this high burden of preterm birth and poor fetal growth in this context. In a substudy in this trial population, we found that vitamin A supplementation (and to a lesser extent b-carotene) reduced the prevalence and incidence of bacterial vaginosis (22)-a condition that increases the risk of preterm birth and LBW. However, the relatively low prevalence of bacterial vaginosis (w5-7%) in the third trimester may have contributed little to the high risk of preterm birth in this population. Our results are also congruent with previously reported findings from the same trial of no effect of either intervention on stillbirth and infant mortality through 12 wk of age (15) .
The estimate of LBW found in our study is consistent with others in Bangladesh, which showed a high prevalence of LBW (w30%) in the Matlab district (23) and in a national survey a prevalence of 37.3% for the Rajshahi division (24); however, at 53.4% prevalence, it is the highest rate published to date, although few estimates are available that are population based. In one study done in neighboring districts in Dhaka, the LBW was 49% in non-National Nutrition Program areas, although the sample size was small and the study area purposely selected to test the program's effect (25) . Our study area was selected based on its exhibiting average-to-below average socioeconomic status, health service utilization, and maternal malnutrition and morbidity (16) . Differences in prevalence estimates may result from methodologic variation in birth capture, timing, and/or precision of birth size measurement and use of community or hospital-based samples in the study.
Although the burden of poor fetal growth restriction was high, our study does not suggest that maternal vitamin A deficiency was a cause. In part, this may be related to maternal diets during pregnancy being somewhat adequate in vitamin A. With the use of dietary recall data, we found that a large proportion of women in this study population had consumed fish, meat, dairy products, and green leafy and yellow fruit and vegetables in the past week-all good sources of vitamin A and b-carotene. In addition, biochemical data on serum retinol concentrations showed that only w7.7% of women in the first trimester and 14.2% women in the third trimester in the placebo group were deficient in vitamin A (serum retinol ,0.7 mmol/L) (15). This suggests that vitamin A deficiency may not be a limiting micronutrient for fetal growth in this population. Few studies have examined the effect of maternal vitamin A supplementation on birth size and gestational duration. Relevant to this study are the findings from a substudy of an earlier, similarly designed randomized, placebo-controlled trial in Nepal that delivered the same weekly dosages of vitamin A and b-carotene to women before, during, and after pregnancy. In this vitamin A-deficient setting, evident by a midpregnancy prevalence of serum hyporetinolemia (,0.70 mmol/L) and a maternal night blindness rate of w12%, supplementation with vitamin A had no effect on any dimension of neonatal size measured between 7 and 14 d of age (8) . In a clinic-based trial among HIV-1-infected women in Tanzania, with lower prevalences of LBW and SGA than in Bangladesh, daily vitamin A (5000 IU) plus b-carotene (32 mg) supplementation throughout pregnancy did not affect the prevalence of LBW (RR: 0.89; 95% CI: 0.61, 1.29), SGA (RR: 0.83; 95% CI: 0.58, 1.18), or preterm birth (RR: 1.06; 95% CI: 0.83, 1.35) (14) . Previous studies showing a positive relation between maternal vitamin A status and birth outcomes have been largely observational in nature and may have not adjusted adequately for confounding. In addition, studies of cord blood concentrations linking low vitamin A with small birth size may suffer from reverse causation.
We noted weak evidence of a small negative (218 g) and isolated effect of b-carotene supplementation on birth weight, with a marginal P value (0.06)-an effect for which we have no plausible explanation and may need further examination in future studies. Our sample size for the newborn vitamin A supplementation trial was large, because it was estimated based on demonstrating reductions of $15% in infant mortality through 6 mo between the vitamin A and placebo groups. Thus, the 4600 sample size per group yielded 80% power to detect a minimum between-group difference of 25 g in measures of birth weight in the study. Thus, our effect estimates had very narrow confidence limits, including for the small negative effect size seen for b-carotene.
Our study design and methodology permitted assessment of a nutritional intervention effect on pregnancy outcomes in this rural population, in which birth assessment and measurement of anthropometric variables are challenging. We used sensitive and precise equipment and well-trained and standardized anthropometrists to conduct birth anthropometric measures. Our study staff was able to reach newborns soon after birth, although early infant deaths and inability to reach them when women went to their parental residence for a delivery resulted in w25% of the infants not being reached: 19% because they were weighed beyond 72 h of life and 7% because they died before they could be weighed or because they had moved out of the study area. Differences between those with and without birth weight depended on the reason for missing data. However, the treatment effect is unlikely to have been modified by the exclusion of these infants, because the proportion excluded because of missing or late weighing was comparable across treatment groups. Gestational age assessment on the basis of LMP is not considered a gold standard measure of the gestational duration of a pregnancy. However, by eliciting menstrual date histories once every 5 wk for several years, as was done in this study, we believe our population became "trained" to provide an accurate recall of this date at the time of interview. The 5-weekly pregnancy surveillance protocol with urine-based testing also enabled us to identify women early in gestation, which reduced the interval of the menstrual recall period. Finally, adherence to supplementation was high and directly observed for w65% of the total doses and supplement groups were balanced on most examined characteristics-factors that allowed us to draw causal inferences regarding the efficacy of the intervention.
In conclusion, we showed in this large trial that neither weekly antenatal vitamin A nor b-carotene supplementation throughout most of pregnancy affected different measures of birth size, gestational length, or risks of LBW, SGA, or preterm birth in this rural setting in northern Bangladesh. However, as summarized in a recent systematic review by van den Broek et al (26) , maternal vitamin A supplementation can reduce the risks of clinical maternal infection, night blindness, and anemia. In Nepal, where maternal mortality risk and vitamin A deficiency were major problems, dietary supplementation of mothers with vitamin A reduced all-cause mortality related to pregnancy (27) . Thus, whereas not efficacious for improving fetal growth or gestational length, there may be many plausible reasons for providing a normal supplemental intake of vitamin A during pregnancy, alone or as part of a multiple micronutrient mixture, in settings where maternal deficiency is suspected to be a public health problem.
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